Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intraarterial, intraarticular and intrathecal use. It enhances radiographic visualization of vascular, joint and spinal structures during imaging procedures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, diagnostic imaging centres and clinics worldwide.

Iomeron, an iodinated contrast agent, is used in radiographic procedures that require enhanced X‑ray attenuation of vascular, joint and cerebrospinal structures.

Angiography: improves visualization of blood vessels during X‑ray imaging. Arthrography: provides contrast for joint space imaging to delineate cartilage and ligaments. Myelography: enhances contrast of the subarachnoid space for spinal imaging.

Iomeron may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Warmth or flushing sensation at the injection site - Metallic taste in the mouth - Nausea or mild vomiting - Transient headache - Mild urticaria or skin erythema - Temporary increase in serum creatinine

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Acute renal impairment, especially in patients with pre‑existing kidney disease - Seizures or neurological disturbances - Severe hypotension or cardiovascular collapse - Pulmonary edema - Persistent severe skin reactions such as Stevens‑Johnson syndrome

Prior to administration, clinicians should evaluate patient history and clinical status.

Assess renal function: verify baseline creatinine and eGFR. Review allergy history: identify prior reactions to iodine‑based agents. Use lowest effective dose: limit iodine load to necessary amount. Monitor vital signs: observe for hemodynamic changes during intra‑arterial injection. Avoid in patients with known iodine hypersensitivity. Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron can interact with other agents that affect renal function or iodine load.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents within 24 hours. - High‑dose iodine‑containing medications (e.g., amiodarone) that increase total iodine exposure.

Moderate Interactions (Monitor Closely): - Metformin: risk of lactic acidosis; consider temporary discontinuation. - ACE inhibitors or ARBs: may exacerbate contrast‑induced nephropathy. - NSAIDs: can impair renal perfusion and increase nephrotoxic risk.